Skip to main content
logo
Tinavi Medical Technologies Co., Ltd. (SHA:688277)
China flag China · Delayed Price · Currency is CNY
17.53
+0.13 (0.75%)
Jul 31, 2026, 3:00 PM CST

SHA:688277 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
272.96278.82178.84210.04156.19156.02
Revenue Growth
30.93%55.90%-14.85%34.48%0.11%14.80%
Gross Profit
181.83192.17124.66138.92102.17105.98
Operating Income
-212.54-179.41-157.73-211.6-174.87-140.86
Net Income
-215.99-182.75-121.13-156.39-110.58-79.93
Earnings Per Share
-0.47-0.40-0.27-0.35-0.26-0.19
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
208.08305.8286.79360.9251.59407.74
Total Debt
190.38197.09198.54219.8998.4270.76
Net Cash (Debt)
17.7108.7188.25141.01153.17336.98
Net Cash Growth
-74.52%23.18%-37.42%-7.94%-54.55%-53.24%
Net Cash Per Share
0.040.240.200.320.360.80

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-122.2-51.17-98.65-170.5-87.51-77.76
Capital Expenditures
-27.86-29.71-36.69-221.03-59.59-238.66
Free Cash Flow
-150.05-80.88-135.34-391.53-147.1-316.42
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
66.62%68.92%69.70%66.14%65.42%67.93%
Operating Margin
-77.86%-64.35%-88.20%-100.74%-111.96%-90.28%
Pretax Margin
-68.81%-55.48%-55.66%-71.74%-92.30%-67.08%
Profit Margin
-79.13%-65.54%-67.73%-74.46%-70.80%-51.23%
FCF Margin
-54.97%-29.01%-75.68%-186.41%-94.18%-202.80%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
29.2824.8425.1028.2031.9670.64